Predictive Oncology
POAI
POAI
26 hedge funds and large institutions have $1.62M invested in Predictive Oncology in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
13% less funds holding
Funds holding: 30 → 26 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$65K | |
| 2 | +$7.37K | |
| 3 | +$5.79K | |
| 4 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
+$5.14K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.19K |
Top Sellers
| 1 | -$60.1K | |
| 2 | -$29K | |
| 3 | -$9K | |
| 4 |
Millennium Management
New York
|
-$6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.33K |